Significantly lower PACAP-38 levels were found in PD patients compared to healthy controls, and we measured, for the first time, significantly increased PACAP-38 levels in patients who received DBS therapy compared to non-treated PD patients. Here, ADCYAP1 is linked to Parkinson disease.